ClinicalTrials.govpublic full text
Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC
gastric cancer, time to progression, overall survival, response rate, quality of live, toxicities, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 868884
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.